Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Regdanvimab Authorized Experimental Antiviral Mar/04/2022 5 4
Tixagevimab Emergency use authorization Experimental Antiviral Jan/26/2022 8 3
Imdevimab Emergency use authorization Experimental Antiviral Jan/26/2022 9 8
Etesevimab Emergency use authorization Experimental Antiviral Jan/26/2022 2 11
Cilgavimab Emergency use authorization Experimental Antiviral Jan/26/2022 8 3
N(4)-Hydroxycytidine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 5 0
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 9 0
PF-00835231 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 5 0
Casirivimab Emergency use authorization Experimental Antiviral Jan/26/2022 4 11
hu33 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022 1 0